차백신연구소: insider trades · South Korea · DART (FSS) DART:company-b7212f KR KR · DART (FSS) Mcap 90.1Bn€ Healthcare
Discover the full management transaction log of 차백신연구소, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 차백신연구소 has published 11 reports. Market capitalisation: €90.1bn. The latest transaction was reported on 11 May 2026 — Sale. Among the most active insiders: 테라배터리솔루션. All data is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 158.6 M€
Gross profit 143.9 M€ 91% margin
Net income −16.04 Bn€ -10115.3% margin
Balance sheet & cash
Market cap 90.13 Bn€
Total debt 8.84 Bn€
Free Cash Flow −11.17 Bn€
Debt / Equity 75%
Profitability & ownership
ROE -81.1%
ROA -23.2%
% insiders 39.5%
% institutions 0.0%
Last declaration on 11 May 2026
Declarations 11 total
Executives ● Sale4 DART
€4m 2,350,000 shares
DART:20260511000468 · 11 May 2026
Executives ● Other4 DART
0
DART:20260511000472 · 11 May 2026
Executives ● Purchase14 DART
€14m 8,948,813 shares @ €1.5398 0.015% mcap 100.0% of flow
DART:20260508000473 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Sale4 DART
€16m 9,035,829 shares
DART:20260508000461 · 8 May 2026
Executives ● Sale4 DART
€3m 1,650,000 shares
DART:20260508000990 · 8 May 2026
Executives ● Other0 DART
DART:20260415000653 · 15 Apr 2026 details not loaded
Executives ● Sale17 DART
€52,173 14,316 shares @ €3.6444 0.0001% mcap 100.0% of flow
DART:20260401002354 · 26 Mar 2026
Executives ● Purchase4 DART
€5m 1,650,000 shares
DART:20260325001321 · 25 Mar 2026
Ideal exit: 20 Dec 2026 (T+270) Executives ● Purchase4 DART
€12m 3,948,813 shares
DART:20260325000239 · 25 Mar 2026
Ideal exit: 20 Dec 2026 (T+270) Executives ● Purchase4 DART
€8m 2,350,000 shares
DART:20260324000927 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Other0 DART
DART:20260310003079 · 10 Mar 2026 details not loaded